[FtsS09F01PriorInformationNotice]

[Information]

[Published]

[ExpireDate]: 12/06/2024

[ExternalReference]: 2024-537469

[FtsReference]: 2024-014973

[FtsS09F01PriorInformationNotice]

[NoticePin]

[Supplies]

[NoticeReducesTimelimits]

[Section1]: [Ca]

I.1)

[NameAddressContact]

Nottingham Trent University (NTU)
GB 277399933
50 Shakespeare Street
Nottingham
NG1 4FQ
UK
[Contactpoint]: Mark Lucas
[AddressPhone]: +44 1158488747
[AddressEmail]: mark.lucas@ntu.ac.uk
[Nutscode]:  UKF14 -  Nottingham
[Internets]:
I.2)

[JointProcurement]

[JointProcurementCentral]
I.3)

[InfoTendering]

[DocsRestricted]:  
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=81558&B=NTU
[AddressFurtherinfo]
[AsContactsAbove]:  
[AddressSendTendersRequest]
[AddressSendTendersRequest]
[AddressToAbove]
I.4)

[CaType]

[MaintypePublicbody]
I.5)

[Mainactivity]

[MainactivEducation]

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

Clinical Trial Manufacturing and Distribution Services
[Fileref]:  NTU/24/2615/ML
II.1.2)

[CpvMain]

33600000  - 
II.1.3)

[TypeContract]

[Supplies]
II.1.4)

[DescrShort]

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.
II.1.5)

[ValueMagnitudeEstimatedTotal]

[ValueExclVat]: 344676.00  GBP
II.1.6)

[LotsInfo]

[DivisionLots]: [No]
II.2)

[Description]

II.2.2)

[CpvAdditional]

33600000  - 
II.2.3)

[PlacePerformance]

[Nutscode]:  UKF14 -  Nottingham
[MainsiteplaceWorksDelivery]:  
England and Wales
II.2.4)

[DescrProcurement]

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.6)

[ValueMagnitudeEstimated]

[ValueExclVat]: 344676.00  GBP
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 48
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.3)

[DateOfContractNotice]:

17.06.2024

[Section3]: [InfoLegal]

III.1)

[ConditionsParticip]

III.1.1)

[SituationPersonalIncl]

[InfoEvaluatingRequir]:  Suitably regulated, accredited and licensed suppliers
III.1.2)

[EconomicFinancialStanding]

[CriteriaSelectionDocs]
III.1.3)

[TechnicalCapacity]

[CriteriaSelectionDocs]
III.2)

[ConditionsContract]

III.2.2)

[OtherConditions]

TBC
III.2.3)

[StaffResponsible]

[StaffResponsibleIndicate]

[Section4]: [Procedure]

IV.1)

[Description]

IV.1.8)

[GpaInfo]

[GpaCovered] : [Yes]
IV.2)

[InfoAdmin]

[Section6]: [InfoComplement]

VI.2)

[InfoEworkflow]

[EorderingUsed]
[EinvoicingUsed]
[EpaymentUsed]
VI.4)

[AppealsProcedure]

VI.4.1)

[AppealsBody]

Royal Courts of Justice
Strand
London
WC2A 2LL
UK

VI.4.2)

[MediationBody]

The Royal Courts of Justice
Strand
London
WC2A 2LL
UK

VI.4.4)

[AppealsInfo]

Royal Courts of Justice
Strand
London
WC2A 2LL
UK